[HTML][HTML] Outcomes and treatment options for duodenal adenocarcinoma: a systematic review and meta-analysis
LL Meijer, AJ Alberga, JK de Bakker… - Annals of surgical …, 2018 - Springer
Background Duodenal adenocarcinoma (DA) is a rare tumor for which survival data per
treatment modality and disease stage are unclear. This systematic review and meta-analysis …
treatment modality and disease stage are unclear. This systematic review and meta-analysis …
[引用][C] Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis
LL Meijer, AJ Alberga, JK de Bakker… - Annals of Surgical …, 2018 - cir.nii.ac.jp
Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and
Meta-Analysis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Meta-Analysis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
[PDF][PDF] Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis
2018 - researchgate.net
Background. Duodenal adenocarcinoma (DA) is a rare tumor for which survival data per
treatment modality and disease stage are unclear. This systematic review and metaanalysis …
treatment modality and disease stage are unclear. This systematic review and metaanalysis …
Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis: A Systematic Review and Meta-Analysis
LL Meijer, AJ Alberga… - Annals of …, 2018 - researchinformation.amsterdamumc …
Background: Duodenal adenocarcinoma (DA) is a rare tumor for which survival data per
treatment modality and disease stage are unclear. This systematic review and meta-analysis …
treatment modality and disease stage are unclear. This systematic review and meta-analysis …
Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis
LL Meijer, AJ Alberga, JK de Bakker… - Annals of surgical …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Duodenal adenocarcinoma (DA) is a rare tumor for which survival data per
treatment modality and disease stage are unclear. This systematic review and meta-analysis …
treatment modality and disease stage are unclear. This systematic review and meta-analysis …
Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis
LL Meijer, AJ Alberga, JK de Bakker… - Annals of Surgical …, 2018 - search.proquest.com
Background Duodenal adenocarcinoma (DA) is a rare tumor for which survival data per
treatment modality and disease stage are unclear. This systematic review and meta-analysis …
treatment modality and disease stage are unclear. This systematic review and meta-analysis …
[HTML][HTML] Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis
LL Meijer, AJ Alberga, JK de Bakker… - Annals of Surgical …, 2018 - ncbi.nlm.nih.gov
Background Duodenal adenocarcinoma (DA) is a rare tumor for which survival data per
treatment modality and disease stage are unclear. This systematic review and meta-analysis …
treatment modality and disease stage are unclear. This systematic review and meta-analysis …
Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis.
LL Meijer, AJ Alberga, JK de Bakker… - Annals of Surgical …, 2018 - europepmc.org
Background Duodenal adenocarcinoma (DA) is a rare tumor for which survival data per
treatment modality and disease stage are unclear. This systematic review and meta-analysis …
treatment modality and disease stage are unclear. This systematic review and meta-analysis …